Should I Buy MYSZ? MYSZ 2026 Analysis

Should You Buy My Size Inc (MYSZ) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Sell

Latest Price

0.800

1 Day change

-3.74%

52 Week Range

3.040

Analysis Updated At

2026/01/30

MYSZ is not a good buy right now for an impatient trader. The chart setup is bearish (downtrend across moving averages + weakening MACD), there are no Intellectia buy signals today, and the short-term pattern stats skew slightly negative over the next week. With price still below the key pivot (0.871) and momentum deteriorating, the higher-probability move is continued chop-to-down rather than a clean upside breakout.

Technical Analysis

Price/levels: Pre-market at 0.8081, sitting just above S1 support (0.795) and below the pivot (0.871). A break below ~0.795 increases risk toward S2 (0.748). Upside needs a reclaim of 0.871, then resistance at 0.948 and 0.995. Trend: Bearish structure with SMA_200 > SMA_20 > SMA_5, signaling the longer-, mid-, and short-term trend are all pointing down. Momentum: MACD histogram is negative (-0.00388) and negatively expanding, implying bearish momentum is strengthening rather than stabilizing. RSI: RSI(6) at 36.427 is weak and approaching oversold, which can allow bounces, but it’s not a confirmed reversal signal by itself. Pattern-based forward view: Similar-pattern stats imply ~50% chance of -0.26% next day, -2.33% next week, and +10.63% next month (mixed near-term, with the weak week bias aligned with current trend). Intellectia Proprietary Trading Signals - [AI Stock Picker](module://ai_stock_pick): no signal on given stock today. - [SwingMax](module://swingmax): No signal on given stock recently.

Options Data

Positive Catalysts

on 2026-02-13 pre-market could act as a speculative catalyst into the date.

Neutral/Negative Catalysts

plus MACD expanding negatively suggests continuation risk.

Financial Performance

Latest quarter: 2025/Q3. Revenue increased to $2.572M (+39.86% YoY), showing strong top-line growth. However, profitability remains weak: net income is still negative at -$1.335M (only a modest improvement YoY), EPS dropped to -0.40 (worse YoY), and gross margin fell to 39.23% (down 8.79% YoY). Net result: growth is improving, but operating quality and per-share results are not yet trending convincingly upward.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so there is no clear Wall Street consensus signal to lean on. Pros (inferred): strong YoY revenue growth could attract speculative interest. Cons (inferred): persistent losses, worsening EPS, and weakening margin profile typically limit bullish analyst conviction, especially in a microcap.

1 Analyst Rating

Wall Street analysts forecast MYSZ stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MYSZ is 3 USD with a low forecast of 3 USD and a high forecast of 3 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 0.829

Low

Averages

High